跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
26-a
首页
药物
26-a
26-a
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
A FULLY HUMAN ANTIBODY SPECIFICALLY INHIBITING CONNEXIN 26
申请人: UNIV SHANGHAI TECHNOLOGY
优先权: 2016
EP
US
2 件公开
26-carboxylic acid triterpenoid compound in keteleeria fortunei, preparation thereof and application of 26-carboxylic acid triterpenoid compound as acetyl-coenzyme A carboxylase inhibitor
申请人: UNIV TAIZHOU
优先权: 2022
CN
Use of MiR-26 family as a predictive marker for hepatocellular carcinoma and responsiveness to therapy
申请人: WANG XIN W
优先权: 2009
US
2 件公开
A novel polypeptide-human U2 snRNP accessory factor small subunit 26-24.86 and polynucleotide for coding said polypeptide
申请人: BODE GENE DEV CO LTD SHANGHAI
优先权: 2000
CN
Methods and compositions for treating and preventing signs or symptoms of eye disease
申请人: JOHNSON LIVING TRUST DATED OCTOBER 26 2001 LEONIDAS A JOHNSON TRUSTEE
优先权: 2014
US
4 件公开
Traditional Chinese medicine for treating pelvic inflammation
申请人: WANG LU
优先权: 2015
CN
Skin-care product containing royal jelly
申请人: WANG LU
优先权: 2016
CN
Ointment for treating burn and its preparing process
申请人: XIAO JIANXUN
优先权: 2004
CN
药物
反馈